The property involved in this transaction is located at 100 Acorn Park Dr, Cambridge, MA. It encompasses a total of 114,490 square feet and is part of a new 280,000 square foot Class A lab, R&D, and office development known as Cambridge Discovery Park, with the specific lease signed for Building 400.

Summary of transaction details:

• Property Type: Lease
• Transaction Amount: Not specified
• Market: Cambridge
• Tenant: FogPharma
• Landlord: The Bulfinch Companies
• Tenant's Representative: Evan Gallagher - Colliers International
• Landlord's Representative: Peter Bekarian - Jones Lang LaSalle
• Current Tenant Space: 22,442 SF in Building 100
• Newly Leased Space: All six floors of Building 400
• Phased Move-in Start: January 2020
• Sublease: Roughly half of the space in Building 400 to LifeMine Therapeutics for first 3-5 years of lease
• Expected Building Delivery: Q1 2020

The deal features key stakeholders including Mike Wilcox, SVP, Director of Leasing at Bulfinch, who expressed enthusiasm for FogPharma's decision to expand within Cambridge Discovery Park. Greg Verdine, Ph.D., President and CEO of FogPharma and LifeMine Therapeutics, articulated the company's growth since its operational start-up and the financial capability to support expansion plans. The construction loan for the CDP Building 400-500 is being led by the Citizens Commercial Real Estate Finance team, reflecting a long-standing collaboration with Bulfinch.